Mr. Assaf Barnea is a seasoned entrepreneur and venture professional, with extensive, multidisciplinary experience in building innovation platforms and leading commercialization processes in healthcare. He leads Sanara Ventures, a healthcare innovation fund backed by Phillips and Teva.

In addition to leading Sanara, Mr. Barnea chairs the Life Science Advisory Board at The Israel Export Institute, on behalf of the Israeli government, promoting and advancing the export of Israeli technologies in the medical, biotech, pharma and digital fields in global markets. A valued consultant, Mr. Barnea also advises the World Bank’s IFC venture capital team and is a co-founder of the IFC’s Tech Emerge initiative; a unique acceleration platform that connects healthcare startups from around the world with leading corporations and hospitals in emerging economies. On December 2018, Tech Emerge Health has won the world bank group president’s award for innovation.

Formerly, Mr. Barnea was one of the founders of CardioSense, a medtech startup company that developed a probe for early shock detection in various medical settings.

Before lending his multidisciplinary acumen to Sanara Ventures, Assaf served as CEO of Kinrot Ventures, spearheading its acquisition by Hutchison Water in 2012. Prior to this, he headed business development at Mekorot, Israel’s national water company, where he oversaw the establishment of WaTech, the Entrepreneurship & Partnership Center for Water Technologies. For his accomplishments in both Mekorot and Kinrot, he received the Cleantech Group’s Innovation Hero Award in April 2013, which recognizes individuals whose commitment, drive and passion have made a tangible difference for innovation in general and specifically for many start-up companies.

Previously, Mr. Barnea served for four years as director of business development at Comverse, where he also co-chaired the Mobile Marketing Association.

A unique highlight in Assaf’s story is his former stint as a college basketball player at New Jersey’s Seton Hall University, where he won the Big East championship against Georgetown. He went on to play professional basketball in Israel’s national league, while completing multiple academic degrees.

A certified lawyer, Mr. Barnea holds both law and business degrees from the Interdisciplinary Center in Herzelia, as well as a BA in political science and psychology from Tel-Aviv University.

Dr. Eran Toledo, is an experienced executive, with a strong background in both academic research and industrial development projects. Prior to joining Sanara Ventures, Eran was VP Research and Development with Aspect Imaging, a well-established startup in the field of MRI, with applications in diagnostic medicine, pre-clinical research, food industry and the oil industry. Earlier, Eran was VP Research and Development with Biological Signal Processing (BSP), a startup that developed a novel marker of ischemic heart disease based on a unique approach to ECG signal analysis. Before joining the private sector, Eran was a Fulbright scholar at the University of Chicago, where he focused on developing quantitative imaging techniques in the field of cardiology. Eran also served as a research officer in the IDF Signal Corps.

Eran is a graduate of the distinguished Talpiot program. He holds a BSc in Physics and Mathematics from the Hebrew University and a PhD in Medical Physics from Tel Aviv University. He has over 10 years of managerial experience in the medical device industry and extensive academic research experience. Eran has authored and co-authored over 35 scientific publications and is the inventor and co-inventor of several medical device patents.

Brigadier General (Ret.) Dr. Daniel Gold is Head of Israel’s Defense Research and Development Directorate (DDR&D- MAFAT) at Israel Ministry of Defense (IMOD) and Israel Defense Forces (IDF)  since July 2016. Dr. Gold is in charge of determining the defense research and development policy for Israel, including oversight of its execution. He is in charge of all R&D, technology infrastructure, full-scale development, capabilities development including special directorates (Space, UAVs, Missiles/Rockets Defense).

Dr. Gold holds two PhDs which he unprecedentedly completed concurrently within a period of two years: a PhD in Electronic Engineering and a PhD in Business Management, both from Tel-Aviv University. He has held several positions within IMOD and the Israel Air Force including management of IMOD and IDF's main key projects such as Head of IMOD/IDF R&D unit, Head of the main UAV/Drones projects, Head of Electronics & Electronic Warfare and Head of Armament & Avionics Divisions.

Dr. Gold also founded the “Gold R&D Technology and Innovation LTD” company which offer both consultancy and business-technology ventures and development. In addition, Dr. Gold was Head of the Israel National Committee for Commercial/Civilian Cyber R&D and is a board member of Israel Brain Technology Organization. In 2012 Dr. Gold was awarded the prestigious National Defense Prize for his initiation and management of the “Iron Dome” missiles/rockets defense system which made its first operational interception just 3 years after program launch.

Under his leadership, the R&D unit has been awarded the National Defense Prize 12 times.

He is a four-time recipient of the Israeli Air Force Prize, a recipient of the Singapore Defence Technology Distinguished Fellowship Award and in 2012 was selected “Man of the Year” by Forbes Magazine-Israel.

Dr. Gold was honored to light the torch during the opening ceremony of Israel’s Independence Day in 2015.

In a national competition on the occasion of Israel’s 70th Anniversary set by the Ministry of Economy and Industry, the Iron Dome – founded by Dr. Gold – was selected as “The Most Innovative Israeli Technology” of all times since the establishment of the state of Israel.

The most recent achievement was the initiation of Israel’s National Technology Center for the Combat against the Corona epidemic. Under Dr. Gold’s leadership this center, and the various ventures coordinated at a national level, combined the defense R&D, academy, industry, start-ups and medical communities to focus the efforts which made a significant contribution to Israel’s success in helping the medical staff while limiting the extent and severity of the epidemic, enabling the gradual return to routine which is currently under way. 

Angela Irony (PhD, MPH, RN) is the Executive Director of Sharon District at Maccabi Healthcare at Maccabi HealthCare Services.

In the last decade she performed senior management positions in Maccabi's headquarters as a co-founder and manager of the telehealth center and as the Chief Nursing and Medical Centers Officer.

Angela has led some innovative ventures concerning telecare and remote monitoring for various populations (e.g. pregnant women, chronic patients, etc). As well, she has led significant strategic programs: "Integration 3600" and "Home Hospitalization, "My Pediatrician" app and more.

Fighting Covid19 she has launched the initiation of remote services for managing and monitoring covid19 patients as well as representing Maccabi in the national forum of struggling the pandemic.

Furthermore, as the executive director of the Sharon district she executes the complex yet successful vaccination project reaching compliance rate of 80%.

Angela is a requested lecturer in universities and colleges. She developed an academic course "Advanced technologies in remote medical services" regarding the implementation of various technologies in current healthcare.

Angela is a mother of two sons and is a nurse by profession.

Michel CALMON holds a Doctorate in Law and is also a graduate of the Bordeaux Institute of Political Studies and the National School of Public Health. After having served as deputy director at the Bordeaux University Hospital (1984-1989), then as deputy to the General Delegate of the Fédération Hospitalière de France (1990-1997), he directed the Center Hospitalier de Chartres for ten years (1998-2007), then for four and a half years the Regional Hospital Center of La Réunion, which he led the transformation into University Hospital (2007-2012). After having exercised for three years the functions of General Councilor of health establishments at Social Affairs General Inspection (2012-2015), he has been Director General of the Fondation Santé Service since April 2015. He also assumes the functions of Vice-President of FNEHAD (National Federation of hospital at home).

Publications:

Treaty on Medical and Hospital Law (Lexis-Nexis Editions): fascicles on the hospital public service, hospital doctors, hospital organization and management

Associate Professor Michael Montalto graduated from medical school at the University of Melbourne in 1986, and completed his PhD there in 1999 on measuring quality in Hospital in the Home care. He has been involved in policy, research and clinical leadership in the area of Hospital in the Home since 1993. He is currently the Unit Head of Hospital in the Home at Epworth Healthcare. He has previously been the Head of Hospital in the Home at Mornington Peninsula Hospital and the Royal Melbourne Hospital, and has been directly involved in the management of approximately 25,000 HIH admissions. Over the last 6 years, he has been involved as a Director of Aged Care Imaging, a mobile Xray service for elderly residents of RACFs. He was successful in obtaining a CMBS rebate for mobile Xray services in RACFs from MSAC, and this commenced in November 2019.

He is the author of over 35 peer reviewed publications, and author of a book. He has been a member of the steering committees of both major evaluations of Hospital in the Home in Victoria, and is currently an executive member of the Australasian Hospital in the Home Society. He is a founding Co-Convener of the World Hospital in the Home Congress, which held the first international meeting of Hospital in the Home in Madrid in 2019.

Prof. Edelman holds tenured faculty appointments in the Department of Medicine at Harvard Medical School, and in the Division of Health Sciences and Technology at the Massachusetts Institute of Technology. He is the director of the Harvard-MIT Biomedical Engineering Center and of MIT’s Clinical Research Center, and the current occupant of the Edward J. Poitras Chair at MIT.

Elazer Edelman received Bachelors and Masters Degrees in Electrical Engineering from the Massachusetts Institute of Technology, an M.D. degree with distinction from Harvard Medical School, and then his Ph.D. in Medical Engineering and Medical Physics from the Massachusetts Institute of Technology. He is board certified in Internal Medicine, and in Cardiovascular Medicine, and currently serves as one of the Core Attending Physicians in the acute coronary care unit at the Brigham and Women’s Hospital of the Harvard Medical School.

His research interests combine his scientific and medical training. His laboratory has earned international recognition in investigation, diagnosis and treatment of various cardiovascular diseases. He and his laboratory have pioneered basic findings in vascular biology and the development and assessment of biotechnology especially at the interface of tissues, devices and materials and in particular imaging in cardiovascular disease and fusion imaging. Most recently he and his students have focused on machine learning and artificial intelligence in the diagnosis and prognostication of critical diseases like aortic stenosis.

Dr. Edelman also directs the Harvard-MIT Biomedical Engineering Center, dedicated to applying the rigors of the physical sciences to elucidate fundamental biologic processes and mechanisms of disease. Many of his findings are now in clinical trial validation. Almost 350 students and postdoctoral fellows have passed through Dr. Edelman's laboratory enabling publications of numerous papers and patents. He is fellow of the American College of Cardiology, American Heart Association, Association of University Cardiologists, American Society of Clinical Investigation, American Institute of Medical and Biological Engineering, and the American Academy of Arts and Sciences, National Academy of Medicine and National Academy of Engineering and National Academy of Inventors. As Chief Scientific Advisor of Science: Translational Medicine, FDA Science board member and board member of KidneyX he has set the tone for the national debate on translational research and innovation.

- Trained in Diving and Hyperbaric Medicine at the Israeli Navy Diving Medical Institute, in Intensive Care at Rambam Hospital and at Ohio State University. Was Chair, Emergency Department, Tel Aviv medical Center 1993-2019.

- Associate Clinical Professor in Emergency Medicine, Tel Aviv University, Visiting Professor University of Eastern Piedmont, Italy, and Staff Member of the European Master of Disaster Medicine.

- Past President of the Israeli Association for Emergency Medicine. Member of the Magen David Adom Board of Directors and Chair of the Medical Advisory Committee.

- CMO Sanara Ventures, Medical Director Diagnostic Robotics.

Mark joined IBM as Chief Medical Officer for Europe, Middle East and Africa in 2018. He has over 20 years' experience as an NHS General Practitioner in West Yorkshire, UK.  He has a long-standing interest in informatics, health policy and system redesign and this has led him to work nationally for 15 years in a number of clinical leadership roles at the Department of Health, Cabinet Office and, most recently, as executive medical director of the NHS Digital.

Mark led an initiative with the US government on common data and health technology standards which led to a landmark agreement between the UK and US governments. He led the health transparency initiatives from cabinet office which led to some of the largest open data initiatives in the world. He was European Medical Director of the global health informatics specialist MedeAnalytics between 2014 and 1027 specialising in population health. He chaired the health analytics committee within the industry group TechUK.

In 2003 he founded one of the largest social enterprise providers in the UK – Local Care Direct, which developed an early model of integrated urgent care using multi-professional groups which continues to cover a population of 3 million people. He is a non executive director of the British Medical Journal.

MD, Specialist and Fellow in Vascular Medicine, eHealth Master degree, European Fellow of Excellence in Vascular Medicine/Angiology, Member of the board of VAS, scientific association of Vascular Medicine and European Public Health Association EPHA  digital health Working Group VAS Representative.

Digital Health Expert of Italian National Health Institute, ISS, TISP Center, Associate Researcher of CNR-ICAR, Italian National Research Council, Medical Director of CIRM, Centro Internazionale Radio Medico.

Coordinator of Digital Health Transformation at ASL Frosinone, Lazio Region, Former CNR (Italian National Research Council) Researcher on telemedicine and peripheral vascular adaptations to the extreme environments (Antarctica, Mount Everest).

Co-Founder and Professor in the first e-Health European Master’s degree, (University of Camerino), co-author of Italian National Telemedicine Guidelines (2014 Ministry of Health) and Chilean Telemedicine and Telehealth Guidelines (2019). Former coordinator of Telemedicine national Committee.

Amrinder Singh joined Medtronic Ventures in 2017. In this role, he supports new investments in the medical device, diagnostics, and healthcare services & solutions space as well as supporting portfolio companies operationally and at the board level.

Prior to joining the team, Mr. Singh led Business Development & Strategy for Medtronic’s services & solutions businesses across the Americas & EMEA regions where he focused on developing and implementing value-based health care strategies for the organization. Prior to that Mr. Singh was with the Medtronic Corporate Strategy group.

Before joining Medtronic, Mr. Singh held Product Management and Engineering positions at Thoratec Corporation, a leading medical device company focused on late stage heart failure.

Mr. Singh graduated from University of California, Davis in Biosystems Engineering, and earned his MBA from Northwestern University, Kellogg School of Management.

Victor Savevski is Chief Innovation Officer and AI Center Director at Humanitas. He is also Adjunct Professor at Humanitas University in Artificial Intelligence and Digital Health Systems in Medicine.

As Chief Digital Officer in Humanitas, he has launched over 50 digital health products, health media platforms, websites, apps and digital therapeutics. Currently being used by over 90 millions users. Starting up and managing a large team of developers, web managers, marketers and project managers to digitalize and grow the digital presence of the hospitals, university and research centers.

Now leading the Humanitas AI Center, focused on research and development on Clinical Applications based on Artificial Intelligence & Machine Learning. Collaborations on numerous A.I projects developed with our team of data scientist, doctors and radiologists together with international institutions. Developing and scaling existing and patient facing digital health products.

Victor is also a contributor for Wired and holds a Medical Engineering degree, a Master of Health Management from SDA Bocconi and a Digital Strategy from Harvard University.

Michal is the Co-Founder and Managing Partner of Triventures and brings over 25 years of experience in medtech and digital health in Israel and the U.S. She co-founded Triventures in 2010 to provide what was then missing in the ecosystem- a deep understanding of commercial integration of innovative technologies into the healthcare system. Triventures was one of the first funds in to focus on digital health in Israel and Michal was the first woman to found and manage a venture capital firm in Israel. Since founding Triventures, Michal has grown the fund into a multi-stage investment platform and industry leader.

Prior to launching Triventures, Michal served for many years in the healthcare start-up ecosystem and held multiple executive positions with GI View, Advanced Stent Technologies (acquired by Boston Scientific), ByPass, TriReme Medical (IPO) andothers. Michal ran several business departments from operations to regulatory and marketing and helped scale and steer the companies towards successful exits.

In 2017, Michal was recognized as one of the 50 most influential women in Israel by Globes, Israel’s leading financial journal and in 2011 she was recognized as one of the 40 most promising leaders in Israel by The Marker, Israel’s leading business journal. With a hands-on approach, Michal is involved in all the fund’s major decisions, leads investments and serves as an active board member in the majority of the portfolio companies.

Professional Experience:  Since October 2020 Galia is Director General of Sheba BEYOND, Israel’s first virtual hospital. Since 2018, she has been serving as the director of the Pediatric Infectious Disease Unit as well as the head of the Telemedicine innovation hub, ARC.  Previously in 2018, she became part of Sheba's management team as a medical administration intern.  Before that Galia worked at Sheba as a consultant for pediatric infectious diseases and as a senior physician in the pediatrics department. 

Medical training: Galia completed her training in Pediatrics at the Kaplan Medical Center in Rehovot, and specialized in Infectious Diseases at the Soroka Medical Center in Be'er Sheva. 

Education: Galia holds an MD and MBA (with distinction) with a specialization in health systems management from the Tel Aviv University. She completed the Inbar Healthcare Management Program, a joint venture of The MAOZ organization with Israel's Ministry of Health.

David Levine, MD MPH MA, is a practicing general internist and clinician-investigator at Brigham Health and Harvard Medical School. He is active in clinical and translational research through a focus on optimizing quality time at home by shifting care home, decentralizing care, digital health technology, and measuring the quality and experience of health care. He is medical director for strategy and innovation for the Brigham Health Home Hospital and co-chair of the Hospital at Home Users Group. He sees his role as helping patients achieve the right care at the right time in the right place by designing, implementing, and evaluating innovative interaction spaces among a care team, technology, caregiver, and a patient.

David received his undergraduate degree from Pomona College in biology and politics. He earned his masters in teaching in special and secondary science education and served as a high school chemistry teacher and science department chair in Chicago Public Schools. He received his medical degree from Washington University in St Louis and completed his residency at New York University and Bellevue Hospital in internal medicine – primary care. He completed a general internal medicine fellowship at Brigham Health and Harvard Medical School and received his masters in public health at the Harvard School of Public Health.